Literature DB >> 30176653

Clinical Utility of Extracorporeal Cytokine Hemoadsorption Therapy: A Literature Review.

Anthony Bonavia1, Andrew Groff2, Kunal Karamchandani1, Kai Singbartl3.   

Abstract

Cytokines play a critical role in coordinating and amplifying a host immune response to infection. The normal pattern of localized and systemic release of proinflammatory and anti-inflammatory cytokines varies on the basis of the disease process. A dysregulated cytokine response can lead to a hyper-inflammatory condition called a cytokine storm. This is believed to contribute to the pathophysiology of sepsis and septic shock, a condition carrying high morbidity and mortality in critically ill patients. Extracorporeal cytokine hemoadsorption is an emerging technology utilized in the treatment of dysregulated inflammatory states such as sepsis, although there is a paucity of clinical evidence supporting its outcomes benefits. We assess the peer-reviewed literature relating to cytokine hemoadsorption in the context of sepsis and suggest areas of future research incorporating this novel technology.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  CytoSorb; Cytokine hemoadsorption; Cytokine storm; Cytokines; Immune dysfunction; Septic shock

Mesh:

Substances:

Year:  2018        PMID: 30176653     DOI: 10.1159/000492379

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  24 in total

Review 1.  Rationale of Hemoadsorption during Extracorporeal Membrane Oxygenation Support.

Authors:  L Christian Napp; Stephan Ziegeler; Detlef Kindgen-Milles
Journal:  Blood Purif       Date:  2019-05-16       Impact factor: 2.614

2.  Extracorporeal Blood Purification Is Appropriate in Critically Ill Patients with COVID-19 and Multiorgan Failure: CON.

Authors:  Kianoush Kashani; Lui G Forni
Journal:  Kidney360       Date:  2021-08-19

3.  Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient.

Authors:  Marianne Alarie; Maggie Savelberg; Danika Vautour; Igo B Ribeiro
Journal:  J Cardiothorac Surg       Date:  2022-07-07       Impact factor: 1.522

4.  Severe anti-thymocyte globulin-induced cytokine release syndrome in a renal transplant patient.

Authors:  J Huh; L Baines; D Talbot; C MacFie
Journal:  Anaesth Rep       Date:  2021-01-13

5.  Bioassay for Endothelial Damage Mediators Retrieved by Hemoadsorption.

Authors:  Maximilian Denzinger; Ludger Staendker; Keno Ehlers; Julian M Schneider; Tanja Schulz; Tabea Hein; Sebastian Wiese; Annika Roecker; Ruediger Gross; Jan Münch; Hendrik Bracht; Eberhard Barth; Manfred Weiss; Michael Georgieff; E Marion Schneider
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

Review 6.  Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?

Authors:  Catalin Constantinescu; Sergiu Pasca; Tiberiu Tat; Patric Teodorescu; Catalin Vlad; Sabina Iluta; Delia Dima; Dana Tomescu; Ecaterina Scarlatescu; Alina Tanase; Olafur Eysteinn Sigurjonsson; Anca Colita; Hermann Einsele; Ciprian Tomuleasa
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751

7.  Experience with hemoadsorption (CytoSorb®) in the management of septic shock patients.

Authors:  Yatin Mehta; Chitra Mehta; Ashish Kumar; Joby Varghese George; Aditi Gupta; Saurabh Nanda; Gourav Kochhar; Arun Raizada
Journal:  World J Crit Care Med       Date:  2020-01-31

8.  Hemoperfusion with HA380 in acute type A aortic dissection patients undergoing aortic arch operation (HPAO): a randomized, controlled, double-blind clinical trial.

Authors:  Jing Yang; Dong Ji; Yue-Qian Zhu; Yun Ren; Xun Zhang; Hong-Yu Dai; Xu Sun; Yi Zhou; Zhi-Yuan Chen; Qing-Guo Li; Hao Yao
Journal:  Trials       Date:  2020-11-23       Impact factor: 2.279

Review 9.  Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.

Authors:  Antonella Fara; Zan Mitrev; Rodney Alexander Rosalia; Bakri M Assas
Journal:  Open Biol       Date:  2020-09-23       Impact factor: 6.411

10.  Cytokine Removal in Critically Ill Patients Requiring Surgical Therapy for Infective Endocarditis (RECReATE): An Investigator-initiated Prospective Randomized Controlled Clinical Trial Comparing Two Established Clinical Protocols.

Authors:  Fabian Gisler; Thibaud Spinetti; Gabor Erdoes; Markus M Luedi; Carmen A Pfortmueller; Anna S Messmer; Hansjörg Jenni; Lars Englberger; Joerg C Schefold
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.